Trial · NCT07882823
Developing Virtual Reality Programs to Address Social Skills Deficits in Youth With ADHD
NCT07882823, Not applicable, Not yet recruiting, Indiana University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Developing Virtual Reality Programs to Address Social Skills Deficits in Youth With ADHD. Trials, record NCT07882823. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882823
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Developing Virtual Reality Programs to Address Social Skills Deficits in Youth With ADHD
- NCT number
- NCT07882823
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 48 participants, estimated
- Lead sponsor
- Indiana University
- Conditions
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Interventions
- VIP Suite
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Perspective Taking from Baseline to Day 30 | Baseline and Day 30 | This measure reflects changes in scores from baseline to post-virtual reality (VR) intervention on the Perspective Taking subscale of the child Interpersonal Reactivity Index (IRI). The Perspective Taking subscale ranges from 0 to 28. The change from baseline to Day 30 is calculated as Day 30 score - Baseline score. Higher scores indicate more improved perspective taking after the VR intervention. |
| Primary | Change in Empathic Concern from Baseline to Day 30 | Baseline and Day 30 | This measure reflects changes in scores from baseline to post-virtual reality (VR) intervention on the Empathic Concern subscale of the child Interpersonal Reactivity Index (IRI). The Empathic Concern subscale ranges from 0 to 28. The change from baseline to Day 30 is calculated as Day 30 score - Baseline score. Higher scores indicate more improved empathy after the VR intervention. |
| Primary | Change in Oppositional/Defiant Behavior from Baseline to Post-Treatment | Baseline, Day 30, and Day 60 | This measure reflects changes in scores on the Oppositional/Defiant subcategory of the parent Disruptive Behavior Disorder (DBD) rating scale. Scores on the scale range from 0 to 3, reflecting an average of individual items that measure the frequency of antisocial behaviors. Two scores will be calculated: Day 30 score - Baseline score and Day 60 score - Baseline score, to reflect changes from Baseline. Results will range from 0 to 3, with lower scores indicating a greater drop in oppositional and defiant behaviors. |
| Primary | Overall score from Modified System Usability Scale (SUS) | Day 30 | This measure reflects overall usability of the VR treatment using the Modified System Usability Scale (SUS), completed by the child. The survey has 13 questions related to the program's overall usability. Individual items range from 1-5, with a higher score indicating stronger agreement. An overall score is calculated as the sum of these items, raning from 13 to 65, with higher scores indicating greater usability of the VR program. |
| Secondary | User Burden Scale (UBS) | Day 30 | Assess parent/guardian-reported ease of use and perceived burden using the User Burden Scale (UBS). The survey has 19 questions related to the program's overall usability. Individual answers are combined into a single score between 19 and 95. Higher scores indicate better usability for the program. |
| Secondary | Social Skills Improvement System - Rating Scale (SSIS-RS) | Baseline and Day 30 | Evaluate scores at baseline and post-VR intervention on the Social Skills Improvement System - Rating Scale (SSIS-RS). The total social skills testing results range from 0-138, with a lower score indicating pro-social behavior. The total problem behavior testing results range from 0-99 with a lower score indicating pro-social behavior. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R43MH140643 | Developing virtual reality programs to address social skills deficits in youth with ADHD | MILLER, KEVIN; WOOD, ZEBULUN MAXWELL | OPENMINDXR LLC | NATIONAL INSTITUTE OF MENTAL HEALTH | 2025 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07882823
GET https://conductscience.org/api/trials/v1/NCT07882823/registered